Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Novo Nordisk has launched two large Phase III trials (EVOKE and EVOKE+) to assess whether semaglutide can slow cognitive decline in participants with early-stage Alzheimers disease
Artemisinin inhibits NRas palmitoylation by targeting the protein acyltransferase ZDHHC6
Sp je uiten vdt, e glutathion je soust irho obrazu a e jeho hladina me reagovat na to, jak lovk dlouhodob ije
Developing GLP-1 therapies specifically optimized for weight management with enhanced efficacy profiles serves the massive global obesity epidemic beyond traditional diabetes care
Efficacy of surgical laser therapy in the management of oral pigmented lesions: a systematic review
US$ 26.73
US$ 28.20
US$ 29.52
:max_bytes(150000):strip_icc()/VWH-GettyImages-2158519129-372ed708fbbb4c6e9f472a8218cd52ee.jpg)
US$ 29.38
